Literature DB >> 56228

Herpes simplex vaccines.

M R Hilleman.   

Abstract

Prospects for the development of vaccines against herpes simplex virus types 1 and 2 and other herpesvirus group vaccines are discussed from the scientific, medical, and economic standpoints. Probably, the most practical development will be glycoprotein subunit vaccines, prepared from herpes simples virus types 1 and 2, that will be tested for prophylaxis and therapy of acute viral disease and for cancer that may be caused by these agents.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 56228

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


  14 in total

1.  Preparation and efficacy of an inactivated subunit vaccine (NFUIBHK) against type 2 Herpes simplex virus infection.

Authors:  G R Skinner; D R Williams; A Buchan; J Whitney; M Harding; K Bodfish
Journal:  Med Microbiol Immunol       Date:  1978-11-17       Impact factor: 3.402

2.  Efficacy of a nucleic acid free herpetic subunit vaccine.

Authors:  R Cappel; F de Cuyper; F Rickaert
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

3.  Mutant analysis of herpes simplex virus-induced cell surface antigens: resistance to complement-mediated immune cytolysis.

Authors:  J C Glorioso; M Levine; T C Holland; M S Szczesiul
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

4.  Human T-lymphocyte response in vitro to synthetic peptides of herpes simplex virus glycoprotein D.

Authors:  E C DeFreitas; B Dietzschold; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

5.  Protection against herpes simplex virus infection in mice by Corynebacterium parvum.

Authors:  H Kirchner; H M Hirt; K Munk
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

6.  Protection from oral herpes simplex virus infection by a nucleic acid-free virus vaccine.

Authors:  E N Kitces; P S Morahan; J G Tew; B K Murray
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

7.  Immunogenic proteins of feline rhinotracheitis virus.

Authors:  R K Maes; S L Fritsch; L L Herr; P A Rota
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

8.  Animal studies on the efficacy of vaccination against recurrent herpes.

Authors:  M Scriba
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402

9.  Immune response to a DNA free herpes simplex vaccine in man.

Authors:  R Cappel; S Sprecher; F Rickaert; F de Cuyper
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

10.  Detection of type-specific antibody to herpes simplex virus type 1 by radioimmunoassay with herpes simplex virus type 1 glycoprotein C purified with monoclonal antibody.

Authors:  A M Arvin; C M Koropchak; A S Yeager; L Pereira
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.